Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19

Clinical Pharmacology and Therapeutics
K S YuS G Shin

Abstract

Moclobemide, an antidepressant with selective monoamine oxidase-A inhibitory action, is known to be metabolized by CYP2C19 and is also reported to be an inhibitor of CYP2C19, CYP2D6, and CYP1A2. To confirm the involvement of CYP2C19, we performed a pharmacokinetic interaction study. The effect of omeprazole on the pharmacokinetics of moclobemide was studied in 16 healthy volunteers. The volunteer group comprised 8 extensive metabolizers and 8 poor metabolizers of CYP2C19, which was confirmed by genotyping. Subjects were randomly allocated into two sequence groups, and a single-blind, placebo-controlled, two-period crossover study was performed. In study I, a placebo was orally administered for 7 days. On the eighth morning, 300 mg of moclobemide and 40 mg of placebo were coadministered with 200 mL of water, and a pharmacokinetic study was performed. During study II, 40 mg of omeprazole was given each morning instead of placebo, and pharmacokinetic studies were performed on the first and eighth day with 300 mg of moclobemide coadministration. The inhibition of moclobemide metabolism was significant in extensive metabolizers even after a single dose of omeprazole. After daily administration of omeprazole for 1 week, the pharmacok...Continue Reading

Citations

Apr 23, 2002·British Journal of Clinical Pharmacology·Joo-Youn ChoDong-Seok Yim
Oct 28, 2010·Drug Metabolism and Pharmacokinetics·Thomas A Baillie, Allan E Rettie
Mar 17, 2010·Annals of Internal Medicine·Wayne A RayC Michael Stein
Apr 27, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoshiyuki ShirasakaNina Isoherranen
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Mar 18, 2004·British Journal of Clinical Pharmacology·Norio Yasui-FurukoriTomonori Tateishi
Jan 30, 2015·The Journal of Antimicrobial Chemotherapy·Norbert HeinrichUNKNOWN Pan African Consortium for the Evaluation of Antituberculosis Antibiotics PanACEA
Oct 22, 2004·Journal of Clinical Pharmacology·Norio Yasui-FurukoriTomonori Tateishi
Feb 20, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ralph-Steven Wedemeyer, Henning Blume
May 25, 2010·Journal of Clinical Pharmacology·Anita Rakic IgnjatovicMilena Pokrajac
Sep 2, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Henning BlumeBarbara S Schug
Dec 19, 2006·Biopharmaceutics & Drug Disposition·Rameshraja PalaparthyLaura A Williams
Nov 2, 2007·Clinical and Experimental Pharmacology & Physiology·Wei ZhangHong-Hao Zhou
Jul 9, 2010·Clinical Pharmacokinetics·Ryuichi Ogawa, Hirotoshi Echizen
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Jun 26, 2004·Clinical Pharmacokinetics·Ichiro IeiriKenji Otsubo
May 6, 2005·Clinical Pharmacokinetics·Catherine LitalienChristophe Faure
Mar 28, 2019·Clinical Pharmacology and Therapeutics·Aleksi TornioJanne T Backman
Sep 10, 2014·Journal of Neural Transmission·Edoardo Spina, Jose de Leon
Jun 1, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tatyana ZvyagaA David Rodrigues
Oct 19, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xavier BoulencFabrice Hurbin
Sep 14, 2006·Pharmacological Reviews·Sharon J Gardiner, Evan J Begg
Jun 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Zhi-Yi ZhangY Nancy Wong
Mar 3, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sirimas SudsakornHanlan Liu
Jan 18, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Carole GiraudAgnès Tran
May 13, 2021·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·C B EapC Hiemke
Jun 9, 2006·Medicina clínica·Hortensia Alonso-NavarroJosé A García-Agúndez
Nov 16, 2007·Pharmacology & Therapeutics·Magnus Ingelman-SundbergCristina Rodriguez-Antona

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.